These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 227432)

  • 1. Why very low density lipoprotein levels are normal in familial hyperchylomicronaemia.
    Berger GM
    Atherosclerosis; 1979 Sep; 34(1):83-6. PubMed ID: 227432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
    Berger GM; Van der Westhuyzen JH; Huskisson J; Bonnici F; Henderson HE
    S Afr Med J; 1982 Feb; 61(8):266-72. PubMed ID: 7058458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
    Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
    Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
    Kondo Y; Kurobane I; Omura K; Sano R; Abe R; Chida N; Tada K
    Tohoku J Exp Med; 1985 Jan; 145(1):1-6. PubMed ID: 3983953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man.
    Rao SN; Cortese C; Miller NE; Levy Y; Lewis B
    FEBS Lett; 1982 Dec; 150(1):255-9. PubMed ID: 7160473
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)].
    Bakker HD; Abeling NG; Rammeloo JA; Jansen H; van Gennip AH
    Ned Tijdschr Geneeskd; 1985 Apr; 129(14):642-5. PubMed ID: 3990858
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence of idiopathic, familial hyperchylomicronaemia in a cat.
    Jones BR; Wallace A; Harding DR; Hancock WS; Campbell CH
    Vet Rec; 1983 Jun; 112(23):543-7. PubMed ID: 6879969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy in cats with inherited primary hyperchylomicronaemia.
    Jones BR; Johnstone AC; Cahill JI; Hancock WS
    Vet Rec; 1986 Sep; 119(11):268-72. PubMed ID: 3022456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
    Kleinmann Y; Oschry Y; Berger GM; Eisenberg S
    Atherosclerosis; 1988 Jun; 71(2-3):197-204. PubMed ID: 3401291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 15. The lipid-lowering effect of dietary proanthocyanidins in rats involves both chylomicron-rich and VLDL-rich fractions.
    Quesada H; Díaz S; Pajuelo D; Fernández-Iglesias A; Garcia-Vallvé S; Pujadas G; Salvadó MJ; Arola L; Bladé C
    Br J Nutr; 2012 Jul; 108(2):208-17. PubMed ID: 22011563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipase function and the accumulation of beta-very-low-density lipoproteins in the plasma of cholesterol-fed rabbits.
    Chang S; Borensztajn J
    Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):745-50. PubMed ID: 8352741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein.
    Mizuguchi K; Yano T; Ishibashi M; Masada A; Mizota M; Saito Y
    Eur J Pharmacol; 1993 Apr; 235(2-3):221-7. PubMed ID: 8508903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.